TrialCancer medicine2020

Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.

Laurie E Steffen McLouth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.